Holen Sie sich die Stockscreener-App
3.785
2.30%
0.085
Handel nachbörslich:
3.79
0.005
+0.13%
Schlusskurs vom Vortag:
$3.70
Offen:
$3.76
24-Stunden-Volumen:
505.27K
Relative Volume:
0.62
Marktkapitalisierung:
$476.52M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-42.06
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
+1.75%
1M Leistung:
-9.88%
6M Leistung:
-25.64%
1J Leistung:
-34.74%
1-Tages-Spanne:
$3.715
$3.83
1-Wochen-Bereich:
$3.47
$3.83
52-Wochen-Spanne:
$3.27
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.785 | 476.52M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Is Cytek Biosciences (NASDAQ:CTKB) Using Too Much Debt? - simplywall.st
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Decreases Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by American Century Companies Inc. - Defense World
KLP Kapitalforvaltning AS Takes $131,000 Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.51 amid market challenges - Investing.com
Trading (CTKB) With Integrated Risk Controls - news.stocktradersdaily.com
Prudential Financial Inc. Has $1.13 Million Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Raymond James Financial Inc. Buys New Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Thrivent Financial for Lutherans Sells 3,001 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra
106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World
Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com India
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World
Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience
Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World
Stephens Reiterates “Overweight” Rating for Cytek Biosciences (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.05 - Investing.com India
Cytek Biosciences stock hits 52-week low at $4.05 By Investing.com - Investing.com UK
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - The Manila Times
Cytek Biosciences Launches Next-Generation Muse Micro Cell Analyzer to Transform Flow Cytometry Accessibility - Nasdaq
Revolutionary Budget-Friendly Cell Analyzer Transforms Biotech Research Accessibility - StockTitan
Bank of New York Mellon Corp Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Proficio Capital Partners LLC Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com Australia
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences (CTKB) to Release Earnings on Wednesday - The AM Reporter
Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN
Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World
Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World
Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks
Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. SEC 10-K Report - TradingView
Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):